Johnson & Johnson Innovation - JJDC Overview
- Investor Type
- Venture Capital
- Status
- Active
- Professionals
- 12
- Investments
- 363
- Portfolio
- 99
- Exits
- 152
Johnson & Johnson Innovation - JJDC General Information
Description
Founded in 1973, Johnson & Johnson Innovation-JJDC is the corporate venture capital arm of Johnson & Johnson based in New Brunswick, New Jersey. The firm prefers to make investments in pharmaceuticals, medical devices, and consumer healthcare sectors.
Contact Information
Website
Formerly Known As
Johnson & Johnson Development Corporation
Year Founded
1973
Investor Status
Actively Seeking New Investments
Trade Association
National Venture Capital Association (NVCA)
Primary Investor Type
Corporate Venture Capital
Other Investor Types
Venture Capital
Primary Office
- 410 George Street
- New Brunswick, NJ 08901
- United States
+1 (732) 000-0000
Johnson & Johnson Innovation - JJDC Investments (363)
| Company Name | Deal Date | Deal Type | Deal Size | Industry | Company Stage | Lead Partner |
|---|---|---|---|---|---|---|
| Paige | 14-Jan-2021 | Later Stage VC | 00000 | Laboratory Services (Healthcare) | Generating Revenue | |
| 000 00000000000000 | 05-Jan-2021 | 00000 00000 | 0000 | Biotechnology | Product Development | |
| 000 000000000000 | 22-Dec-2020 | 00000 00000 | 000.00 | Biotechnology | Generating Revenue | |
| 0000000 | 09-Nov-2020 | 00000 00000 | 00.000 | Personal Products | Generating Revenue | |
| 0-0000 | 22-Sep-2020 | 00000 00000 | 0000 | Therapeutic Devices | Clinical Trials - General | |
| 00 000000000000 | 18-Sep-2020 | 00000 00000 | 0000 | Drug Discovery | Pre-Clinical Trials | |
| 000000 000 | 14-Sep-2020 | 00000 00000 | 0000 | Biotechnology | Clinical Trials - Phase 1 | 00000 000000 00.0 |
| 000000 | 26-Aug-2020 | 00000 00000 | 0000 | Decision/Risk Analysis | Generating Revenue | |
| GI Windows | 19-Aug-2020 | Later Stage VC | 000.00 | Surgical Devices | Generating Revenue | 0.00000 0000000000 00.0 |
| ImmPACT-Bio | 18-Aug-2020 | Early Stage VC | 0000 | Biotechnology | Generating Revenue |
Johnson & Johnson Innovation - JJDC Exits (149)
| Company Name | Exit Date | Exit Type | Exit Size |
|---|---|---|---|
| Fusion Pharmaceuticals | 26-Jun-2020 | IPO | 00000 |
| 0000000 | 12-Jun-2020 | 000 | 00000 |
| 000000 0000000 | 05-Jun-2020 | 000 | 00000 |
| 00000000 | 02-Jun-2020 | 0000000000: 000000 | |
| 00000 000000 | 14-May-2020 | 000000000000000000 | |
| 000000 | 06-Apr-2020 | 0000000000: 000000 | |
| 000000 0000000 | 24-Jan-2020 | 000000000000000000 | 00000 |
| 00000000 | 15-Jan-2020 | 000000000000000000 | 0000 |
| Rodin Therapeutics | 25-Nov-2019 | Merger/Acquisition | 00000 |
| NeuroSearch | 07-Oct-2019 | Merger/Acquisition |
Johnson & Johnson Innovation - JJDC Investments by Industry, Year, and Region
Investments by Industry
Investments by Year
Investments by Region
PitchBook’s data visualizations quickly surface an investor’s historical investments—showing a breakdown of activity by industry, year and region.
Request a free trialJohnson & Johnson Innovation - JJDC Team (45)
| Name | Title | Deals | Funds | Boards | Office |
|---|---|---|---|---|---|
| Chris Picariello | President | New Brunswick, NJ | |||
| Claire Leurent Ph.D | Principal, Venture Investments | Boston, MA | |||
| Anurag Mehta | Principal, Venure Investments | New York, NY | |||
| Dan Wang | Head | New Brunswick, NJ | |||
| Michal Preminger Ph.D | Head | 0 | New Brunswick, NJ |
Johnson & Johnson Innovation - JJDC Co-Investors (340)
| Name | With | Exits | Lead Partner | Series | Industry |
|---|---|---|---|---|---|
| Alexandria Venture Investments | 6 | 0 |
|
|
|
| Novartis Venture Fund | 0 | 0 |
|
|
|
| OrbiMed | 0 | 0 |
|
|
|
| ARCH Venture Partners | 0 | 0 |
|
|
|
| Osage University Partners | 0 | 0 |
|
|